Wall Street Legend Issues New NVDA Warning

Legendary Stockpicker: "Buy this A.I. stock NOW" His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock.

Glenn Whaley Biography and Net Worth

Insider of Immunic

Glenn Whaley, CPA, joined Immunic as Principal Accounting Officer and Controller in December 2019. In April 2020, he was promoted to the position of Vice President Finance, Principal Financial and Accounting Officer. Mr. Whaley brings to Immunic more than 30 years of experience in accounting and finance.
Prior to joining Immunic, from March 2015 until May 2019, Mr. Whaley held roles of increasing responsibility at specialty pharmaceuticals company, Pernix Therapeutics, most recently serving as Vice President of Finance. Previously, Mr. Whaley was Vice President of Finance for Alvogen, Inc, a global pharmaceutical company; Corporate Controller for ImClone Systems, a biopharmaceutical company dedicated to developing biologic medicines in the area of oncology; and served in various, key financial roles in public accounting and in the pharmaceutical and telecommunications industries.
Mr. Whaley earned a Bachelor of Science degree from Rutgers University Business School and is a Member of the New Jersey Society of Certified Public Accountants and the American Institute of Certified Public Accountants.

What is Glenn Whaley's net worth?: The estimated net worth of Glenn Whaley is at least $31,122.20 as of May 15th, 2023. Mr. Whaley owns 25,510 shares of Immunic stock worth more than $31,122 as of April 25th. This net worth estimate does not reflect any other investments that Mr. Whaley may own. Additionally, Mr. Whaley receives a salary of $522,210.00 as Insider at Immunic. Learn More about Glenn Whaley's net worth.
How old is Glenn Whaley?: Mr. Whaley is currently 56 years old. There are 5 older executives and no younger executives at Immunic. The oldest executive at Immunic is Dr. Andreas Muehler M.D., Ph.D., Chief Medical Officer, who is 59 years old. Learn More on Glenn Whaley's age.
What is Glenn Whaley's salary?: As the Insider of Immunic, Inc., Mr. Whaley earns $522,210.00 per year. There are 2 executives that earn more than Mr. Whaley. The highest earning executive at Immunic is Dr. Daniel Vitt Ph.D., CEO, President & Director, who commands a salary of $728,400.00 per year. Learn More on Glenn Whaley's salary.
How do I contact Glenn Whaley?: The corporate mailing address for Mr. Whaley and other Immunic executives is 1200 AVENUE SUITE 200, NEW YORK NY, 10036. Immunic can also be reached via phone at (332) 255-9818 and via email at [email protected]. Learn More on Glenn Whaley's contact information.
Has Glenn Whaley been buying or selling shares of Immunic?: Glenn Whaley has not been actively trading shares of Immunic over the course of the past ninety days. Most recently, on Monday, May 15th, Glenn Whaley bought 5,000 shares of Immunic stock. The stock was acquired at an average cost of $1.75 per share, with a total value of $8,750.00. Following the completion of the transaction, the chief financial officer now directly owns 25,510 shares of the company's stock, valued at $44,642.50. Learn More on Glenn Whaley's trading history.
Who are Immunic's active insiders?: Immunic's insider roster includes Duane Nash (Chairman), Daniel Vitt (CEO), and Glenn Whaley (Insider). Learn More on Immunic's active insiders.
Are insiders buying or selling shares of Immunic?: In the last twelve months, Immunic insiders bought shares 1 times. They purchased a total of 5,000 shares worth more than $8,750.00. The most recent insider tranaction occured on May, 15th when CFO Glenn Whaley bought 5,000 shares worth more than $8,750.00. Insiders at Immunic own 2.7% of the company. Learn More about insider trades at Immunic.
Information on this page was last updated on 5/15/2023.

Glenn Whaley Insider Trading History at Immunic

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/15/2023	Buy	5,000	$1.75	$8,750.00	25,510
11/7/2022	Buy	5,000	$1.50	$7,500.00	20,510
6/3/2022	Buy	3,500	$3.04	$10,640.00	12,568
5/12/2022	Buy	3,000	$5.08	$15,240.00	9,068
8/10/2021	Buy	1,500	$9.85	$14,775.00	3,500
8/10/2020	Buy	1,000	$18.96	$18,960.00	1,000

Glenn Whaley Buying and Selling Activity at Immunic

Immunic Company Overview

Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical trial, for treatment of multiple sclerosis, including relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company is also developing IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York.

Today's Range

Now: $1.22

$1.20

$1.23

50 Day Range

MA: $1.33

$1.18

$1.53

2 Week Range

Now: $1.22

$0.95

$3.11

Volume

57,654 shs

Average Volume

839,359 shs

Market Capitalization

$109.71 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.07

Wall Street Legend Issues New NVDA Warning

From Chaikin Analytics | Ad

Legendary Stockpicker: "Buy this A.I. stock NOW" His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock.

Click here for the stock details

Glenn Whaley Biography and Net Worth

What is Glenn Whaley's net worth?

How old is Glenn Whaley?

What is Glenn Whaley's salary?

How do I contact Glenn Whaley?

Has Glenn Whaley been buying or selling shares of Immunic?

Who are Immunic's active insiders?

Are insiders buying or selling shares of Immunic?